AccuStem Sciences, Inc. Announces Chairman Purchase of Shares

Rhea-AI Impact

(Neutral)

Rhea-AI Sentiment

(Neutral)

Rhea-AI Summary

AccuStem Sciences (OTCQB: ACUT), a clinical stage diagnostics company focused on cancer patient outcomes, announced that Board Chairman Gabriele Cerrone has purchased an additional 5,000 shares of ACUT stock in the open market. This acquisition increases Cerrone's total holdings to 4,915,759 shares of the company.

Positive

Chairman's insider buying demonstrates management confidence
Significant insider ownership with Chairman holding nearly 5 million shares

Negative

None.

04/21/2025 - 07:00 AM

LONDON and PHOENIX, Ariz., April 21, 2025 (GLOBE NEWSWIRE) -- AccuStem Sciences, Inc. (OTCQB: ACUT), a clinical stage diagnostics company dedicated to improving outcomes for patients with cancer, announced that its Chairman of the Board, Mr. Gabriele Cerrone, has notified the Company that he has recently purchased an additional 5,000 ACUT shares in the open market. This brings his total holding to 4,915,759 shares.

About AccuStem

AccuStem is a clinical stage diagnostics company dedicated to optimizing outcomes and quality of life for all patients with cancer. We plan to drive innovation in healthcare by offering proprietary molecular testing that addresses unmet clinical needs from cancer screening through treatment and monitoring. By interrogating novel disease pathways, such as tumor “stemness,” we believe our tools will help care teams better understand the biology of each patient’s cancer, leading to more informed decision making.
For more information, please visit www.accustem.com.

Investor and Media Contact:
Wendy Blosser
Email: investors@accustem.com

FAQ

How many ACUT shares did AccuStem's Chairman purchase in April 2025?

AccuStem's Chairman Gabriele Cerrone purchased 5,000 additional ACUT shares in the open market.

What is the total number of shares held by AccuStem's Chairman after the recent purchase?

After the recent purchase, Chairman Gabriele Cerrone's total holdings increased to 4,915,759 ACUT shares.

When did AccuStem's Chairman increase his stake in the company?

The Chairman's additional share purchase was announced on April 21, 2025.

What does the Chairman's share purchase indicate about ACUT stock?

The Chairman's share purchase may signal confidence in the company's future prospects, as insider buying often indicates management's positive outlook.